Journal of Neuroscience · 1996 · 58 citations · 0 references
Life SciencesCell BiologyPharmacologyApoptosisCell SignalingSignal TransductionAntibody CharacterizationApoptosis ModulationApoptosis RegulationApoptotic SignalingDeath ReceptorsTherapeutic Monoclonal AntibodiesAgonist ActivityApoptotic Neuronal DeathLigand Binding AffinityNerve Growth Factor Receptor SignalingNerve Growth Factor SignalingProtein Tyrosine PhosphorylationTrka SignalingTrkb Signaling
Monoclonal antibody (mAb) 5C3 directed against human p140 TrkA is a structural and functional mimic of nerve growth factor (NGF) and an artificial receptor agonist. mAb 5C3 binds in the NGF-docking site and, like NGF, it promotes TrkA internalization, TrkA and phosphatidylinositol-3 kinase tyrosine phosphorylation, and increased transformation of TrkA-expressing fibroblasts. More important, mAb 5C3 protects human TrkA-expressing cells from apoptotic death in serum-free media. Interestingly, agonistic activity is observed with monomeric F(ab) 5C3 fragments. mAb 5C3 (Kd approximately 2 nM) was used to study features of ligand binding by TrkA and the distribution of TrkA protein in normal human brain.